pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4265 |
Genomic Coordinates | chr2: 109141490 - 109141588 |
Description | Homo sapiens miR-4265 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4265 | ||||||||||||||||||
Sequence | 71| CUGUGGGCUCAGCUCUGGG |89 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FXYD5 | ||||||||||||||||||||
Synonyms | DYSAD, HSPC113, IWU1, KCT1, OIT2, PRO6241, RIC | ||||||||||||||||||||
Description | FXYD domain containing ion transport regulator 5 | ||||||||||||||||||||
Transcript | NM_001164605 | ||||||||||||||||||||
Other Transcripts | NM_014164 , NM_144779 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FXYD5 | |||||||||||||||||||||
3'UTR of FXYD5 (miRNA target sites are highlighted) |
>FXYD5|NM_001164605|3'UTR 1 GTCCATCAGAAACAGGAGCTGACAACCTGCTGGGCACCCGAAGACCAAGCCCCCTGCCAGCTCACCGTGCCCAGCCTCCT 81 GCATCCCCTCGAAGAGCCTGGCCAGAGAGGGAAGACACAGATGATGAAGCTGGAGCCAGGGCTGCCGGTCCGAGTCTCCT 161 ACCTCCCCCAACCCTGCCCGCCCCTGAAGGCTACCTGGCGCCTTGGGGGCTGTCCCTCAAGTTATCTCCTCTGCTAAGAC 241 AAAAAGTAAAGCACTGTGGTCTTTGCCCCAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | HEK293 | |||||||||
Disease | 53827.0 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000588699.1 | 3UTR | CCACACCUAUAACCCCAGCACUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
47 hsa-miR-4265 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT061451 | NEK7 | NIMA related kinase 7 | 2 | 2 | ||||||||
MIRT121365 | RNF4 | ring finger protein 4 | 2 | 2 | ||||||||
MIRT184855 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT458214 | SHMT2 | serine hydroxymethyltransferase 2 | 2 | 2 | ||||||||
MIRT468493 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT470574 | POTEM | POTE ankyrin domain family member M | 2 | 2 | ||||||||
MIRT470604 | POTEG | POTE ankyrin domain family member G | 2 | 2 | ||||||||
MIRT470897 | PLIN3 | perilipin 3 | 2 | 2 | ||||||||
MIRT484480 | SLC9A1 | solute carrier family 9 member A1 | 2 | 2 | ||||||||
MIRT486669 | WDR81 | WD repeat domain 81 | 2 | 2 | ||||||||
MIRT490907 | STRN4 | striatin 4 | 2 | 2 | ||||||||
MIRT493426 | KCNK3 | potassium two pore domain channel subfamily K member 3 | 2 | 2 | ||||||||
MIRT504168 | FAM127B | retrotransposon Gag like 8A | 2 | 2 | ||||||||
MIRT510345 | ZNF703 | zinc finger protein 703 | 2 | 6 | ||||||||
MIRT514287 | FXYD5 | FXYD domain containing ion transport regulator 5 | 2 | 2 | ||||||||
MIRT520125 | WSB1 | WD repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT522065 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT530484 | FADS6 | fatty acid desaturase 6 | 2 | 2 | ||||||||
MIRT536055 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT546050 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 4 | ||||||||
MIRT549084 | C5orf51 | chromosome 5 open reading frame 51 | 2 | 4 | ||||||||
MIRT551250 | NLRP9 | NLR family pyrin domain containing 9 | 2 | 2 | ||||||||
MIRT559432 | ARSJ | arylsulfatase family member J | 2 | 2 | ||||||||
MIRT565560 | SMAD5 | SMAD family member 5 | 2 | 2 | ||||||||
MIRT566348 | POLDIP2 | DNA polymerase delta interacting protein 2 | 2 | 2 | ||||||||
MIRT572109 | DNAJC24 | DnaJ heat shock protein family (Hsp40) member C24 | 2 | 2 | ||||||||
MIRT572646 | ID4 | inhibitor of DNA binding 4, HLH protein | 2 | 2 | ||||||||
MIRT608936 | SATB1 | SATB homeobox 1 | 2 | 2 | ||||||||
MIRT610608 | ARHGAP18 | Rho GTPase activating protein 18 | 2 | 2 | ||||||||
MIRT612582 | SYNGAP1 | synaptic Ras GTPase activating protein 1 | 2 | 4 | ||||||||
MIRT628951 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | 2 | 2 | ||||||||
MIRT631030 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT633020 | DNAL1 | dynein axonemal light chain 1 | 2 | 2 | ||||||||
MIRT633252 | ZNF581 | zinc finger protein 581 | 2 | 2 | ||||||||
MIRT637165 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT637264 | KLHL12 | kelch like family member 12 | 2 | 2 | ||||||||
MIRT641366 | RABGEF1 | RAB guanine nucleotide exchange factor 1 | 2 | 2 | ||||||||
MIRT653808 | SIN3A | SIN3 transcription regulator family member A | 2 | 2 | ||||||||
MIRT663202 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT694269 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT708318 | NT5C | 5', 3'-nucleotidase, cytosolic | 2 | 2 | ||||||||
MIRT710038 | POLL | DNA polymerase lambda | 2 | 2 | ||||||||
MIRT717092 | PXDC1 | PX domain containing 1 | 2 | 2 | ||||||||
MIRT721739 | SDK2 | sidekick cell adhesion molecule 2 | 2 | 2 | ||||||||
MIRT721877 | TMPRSS6 | transmembrane protease, serine 6 | 2 | 2 | ||||||||
MIRT723340 | SCRT1 | scratch family transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT725561 | CPT1A | carnitine palmitoyltransferase 1A | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|